Beijing, Beijing, China | Fund Name | Location |
| Ark Challenge | Arkansas, Fayetteville, United States |
| Cannabis Growth Opportunity Corp | Canada, Ontario, Toronto |
| Deutsche Kreditbank | Berlin, Berlin, Germany |
| Dragoneer Investment Group | California, San Francisco, United States |
| Gaolan Capital | Beijing, China, Haidian |
| HT Media Ltd | Delhi, India, New Delhi |
| IDG-Accel China Growth Fund | Beijing, Beijing, China |
| La Roquette | Comunidad Valenciana, Spain, Valencian Community |
| Lead Dog Ventures | Massachusetts, United States, Wayland |
| Milar Ventures | - |
| OGIS-RI | Japan, Osaka, Osaka Prefecture |
| Pacifica Enterprises | - |
| R.W. Pressprich & Co | New York, New York, United States |
| Raymonds Capital, LLC | - |
| RCI Bank and Services | France, Ile-de-France, Paris |
| Shenzhen Woer Heat-Shrinkable Material | China, Guangdong Province, Pingshan District |
| SoulCycle | New York, New York, United States |
| VYSYN Capital | - |
| WLD Equity Partners | California, San Jose, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
No. 1 workplace | 05 May 2022 | Changning, Shanghai, China | |||
AutoBrain | 30 Dec 2021 | China, Beijing, China | |||
Elixiron Immunotherapeutics | $27M | 23 Aug 2021 | New Taipei, Taiwan | ||
| $12M | 05 May 2021 | Sunnyvale, California, United States | |||
Airmb.com | $1M | 17 Sep 2018 | Yuexiu District, Guangdong Province, China | ||
Joychuang | $2M | 21 May 2015 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
No. 1 workplace | 05 May 2022 | Changning, Shanghai, China | |||
AutoBrain | 30 Dec 2021 | China, Beijing, China | |||
Elixiron Immunotherapeutics | $27M | 23 Aug 2021 | New Taipei, Taiwan | ||
| $12M | 05 May 2021 | Sunnyvale, California, United States | |||
Airmb.com | $1M | 17 Sep 2018 | Yuexiu District, Guangdong Province, China | ||
Joychuang | $2M | 21 May 2015 | Dongcheng District, Beijing, China |
